Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.
- DOI
- 10.1038/s41598-026-46185-7
- Published
- 2026 Apr 3
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-026-46185-7,
title = {Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.},
author = {Takada S and Nasu I and Uozumi R and Kondo M and Nawata S and Iihara H and Okumura Y and Hashishita H and Takemoto M and Okada T and Kitamura Y and Oizumi S and Fukuda S and Kusumoto S and Endo J and Kawazoe H and Nakamura T},
year = {2026},
journal = {Scientific reports},
doi = {10.1038/s41598-026-46185-7},
url = {https://doi.org/10.1038/s41598-026-46185-7}
}RIS
TY - JOUR TI - Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer. AU - Takada S AU - Nasu I AU - Uozumi R AU - Kondo M AU - Nawata S AU - Iihara H AU - Okumura Y AU - Hashishita H AU - Takemoto M AU - Okada T AU - Kitamura Y AU - Oizumi S AU - Fukuda S AU - Kusumoto S AU - Endo J AU - Kawazoe H AU - Nakamura T PY - 2026 JO - Scientific reports DO - 10.1038/s41598-026-46185-7 UR - https://doi.org/10.1038/s41598-026-46185-7 ER -
APA
S, T., I, N., R, U., M, K., S, N., H, I., Y, O., H, H., M, T., T, O., Y, K., S, O., S, F., S, K., J, E., H, K., & T, N. (2026). Association of immune-related adverse events with survival in patients receiving immune checkpoint inhibitor plus chemotherapy for lung cancer.. Scientific reports. https://doi.org/10.1038/s41598-026-46185-7
Source records
- pubmed · retrieved 2026-09-27T06:44:49.281Z